Shares of Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report) were up 1.2% on Thursday . The stock traded as high as $4.15 and last traded at $4.15. Approximately 2,003 shares traded hands during trading, an increase of 301% from the average daily volume of 500 shares. The stock had previously closed at $4.10.
Sigyn Therapeutics Price Performance
The firm has a 50 day moving average of $3.68 and a two-hundred day moving average of $4.56.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Further Reading
- Five stocks we like better than Sigyn Therapeutics
- How to invest in marijuana stocks in 7 steps
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
